Browse > Article

Independent Prognostic Value of the Fascin Expression in Patients with Esophageal Cancer  

Choi, Pill-Jo (Department of Thoracic and Cardiovascular Surgery, Dong-A University Hospital, College of Medicine, Dong-A University)
Jeong, Sang-Seok (Department of Thoracic and Cardiovascular Surgery, Dong-A University Hospital, College of Medicine, Dong-A University)
Bang, Jung-Heui (Department of Thoracic and Cardiovascular Surgery, Dong-A University Hospital, College of Medicine, Dong-A University)
Cho, Kwang-Jo (Department of Thoracic and Cardiovascular Surgery, Dong-A University Hospital, College of Medicine, Dong-A University)
Woo, Jong-Soo (Department of Thoracic and Cardiovascular Surgery, Dong-A University Hospital, College of Medicine, Dong-A University)
Roh, Mee-Sook (Department of Pathology, Dong-A University Hospital, College of Medicine, Dong-A University)
Publication Information
Journal of Chest Surgery / v.41, no.1, 2008 , pp. 74-81 More about this Journal
Abstract
Background: Fascin is an actin-bundling protein that induces membrane protrusions and it increases cell motility in various transformed cells. Esophageal cancer is one of the most lethal malignancies, and it exhibits extensive local invasion or frequent regional lymph node metastasis even after curative surgery. We investigate the expression of fascin by performing immunohistochemistry to evaluate the clinical characteristics and prognostic significance of its expression in esophageal cancer patients. Material and Method: Immunochemistry for fascin was performed on 76 tumor samples from 76 patients who underwent esophageal cancer operations. The expression levels of fascin in the 76 esophageal cancer tissues were compared with those in the corresponding normal esophageal epithelium. The fascin-positive samples were defined as those showing more than 75% of fascin-positive cells. Result: Overall, a fascin positive expression was detected in 39 (51.3%) out of the total 76 cases. The tumors with positive fascin expression tended to more frequently show a higher stage (p=0.030), and a higher T-factor (p=0.031). The prognosis of the fascin negative group was significantly better than that of the fascin positive group (p=0.004). Multivariate analysis revealed that lymphovascular invasion and the fascin expression were independent prognostic factors. Conclusion: Fascin was expressed in 513% of the esophageal cancer tissues and a positive expression of fascin was associated with more advanced tumor progression and recurrence. Our study suggests that the fascin expression may be an independent prognostic factor for an unfavorable clinical course few those patients suffering with esophageal cancer.
Keywords
Esophageal neoplasms; Immunohistochemistry; Neoplasm proteins; Neoplasm marker;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-83   DOI   ScienceOn
2 Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-9   DOI   ScienceOn
3 Tilney LG, Connelly PS, Vranich KA, Shaw MK, Guild GM. Why are two different cross-linkers necessary for actin bundle formation in vivo and what does each cross-link contribute? J Cell Biol 1998;143:121-33   DOI   ScienceOn
4 Jawhari AU, Buda A, Jenkins M, et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003; 162:69-80   DOI   PUBMED   ScienceOn
5 Pelosi G, Pastorino U, Pasini F, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-47   DOI   ScienceOn
6 Pelosi G, Pasini F, Fraggetta F, et al. Independent prognostic value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 2003;42:203-13   DOI   ScienceOn
7 Goncharuk VN, Ross JS, Carlson JA. Actin-bundling protein fascin expression in skin neoplasia. J Cutan Pathol 2002; 29:430-8   DOI   ScienceOn
8 Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994;5:165-74
9 Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83:870-3   DOI   ScienceOn
10 Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-70   DOI   ScienceOn
11 Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989;86:1254-8   DOI
12 Otto JJ. Actin-bundling proteins. Curr Opin Cell Biol 1994; 6:105-9   DOI   PUBMED   ScienceOn
13 Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002; 118:52-9   DOI   ScienceOn
14 Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC. Fascins, and their roles in cell structure and function. Bioessays 2002;24:350-61   DOI   ScienceOn
15 Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Increases expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000;18:83-8   DOI   ScienceOn
16 Hashimoto Y, Ito T, Inoue H, et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005;11:2597-605   DOI   ScienceOn
17 Zhang H, Xu L, Xiao D, et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006;59:958-64   DOI   ScienceOn